Type 2 Iodothyronine Deiodinase is the Major Source of Plasma T3 in Euthyroid Humans

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2005 Aug 30

PMID 16127464

Citations 108

Authors

Ana Luiza Maia

Brian W Kim

Stephen A Huang

John W Harney

P Reed Larsen

Affiliations

Soon will be listed here.

Abstract

The relative roles of the types 1 and 2 iodothyronine deiodinases (D1 and D2) in extrathyroidal 3,5,3'-triiodothyronine (T3) production in humans are unknown. We calculated the rate of thyroxine (T4) to T3 conversion by intact cells transiently expressing D1 or D2 at low (2 pM), normal (20 pM), and high (200 pM) free T4 concentrations. Deiodinase activities were then assayed in cell sonicates. The ratio of T3 production in cell sonicates (catalytic efficiency) was multiplied by the tissue activities reported in human liver (D1) and skeletal muscle (D2). From these calculations, we predict that in euthyroid humans, D2-generated T3 is 29 nmol/d, while that of D1-generated T3 is 15 nmol/d, from these major deiodinase-expressing tissues. The total estimated extrathyroidal T3 production, 44 nmol/d, is in close agreement with the 40 nmol T3/d based on previous kinetic studies. D2-generated T3 production accounts for approximately 71% of the peripheral T3 production in hypothyroidism, but D1 for approximately 67% in thyrotoxic patients. We also show that the intracellular D2-generated T3 has a greater effect on T3-dependent gene transcription than that from D1, which indicates that generation of nuclear T3 is an intrinsic property of the D2 protein. We suggest that impairment of D2-generated T3 is the major cause of the reduced T3 production in the euthyroid sick syndrome.

Citing Articles

A DIO2 missense mutation and its impact on fetal response to PRRSV infection.

Ko H, Pasternak J, Mulligan M, Hamonic G, Ramesh N, MacPhee D BMC Vet Res. 2024; 20(1):255.

PMID: 38867209 PMC: 11167750. DOI: 10.1186/s12917-024-04099-4.

Determination of Frequency of Type 2 Deiodinase Thr92Ala Polymorphism (rs225014) in I-treated Differentiated Thyroid Cancer Patients Undertaking L-thyroxine (L-T4) Suppression Therapy.

Gawandi S, Jothivel K, Kulkarni S Indian J Nucl Med. 2024; 39(1):24-28.

PMID: 38817730 PMC: 11135370. DOI: 10.4103/ijnm.ijnm_120_23.

Factors and Mechanisms of Thyroid Hormone Activity in the Brain: Possible Role in Recovery and Protection.

Sabatino L, Lapi D, Del Seppia C Biomolecules. 2024; 14(2).

PMID: 38397435 PMC: 10886502. DOI: 10.3390/biom14020198.

The ageing thyroid: implications for longevity and patient care.

van Heemst D Nat Rev Endocrinol. 2023; 20(1):5-15.

PMID: 37923847 DOI: 10.1038/s41574-023-00911-7.

Case report: Impact of hyperthyroidism on psychotic symptoms in schizophrenia comorbid with Graves' disease.

Sumi Y, Kawahara S, Fujii K, Yamaji M, Nakajima K, Nakamura T Front Psychiatry. 2023; 14:1219049.

PMID: 37496682 PMC: 10366534. DOI: 10.3389/fpsyt.2023.1219049.

References

Gereben B, Goncalves C, Harney J, Larsen P, Bianco A . Selective proteolysis of human type 2 deiodinase: a novel ubiquitin-proteasomal mediated mechanism for regulation of hormone activation. Mol Endocrinol. 2000; 14(11):1697-708. DOI: 10.1210/mend.14.11.0558. View

Canani L, Capp C, Dora J, Meyer E, Wagner M, Harney J . The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2005; 90(6):3472-8. DOI: 10.1210/jc.2004-1977. View

Buettner C, Harney J, Larsen P . The role of selenocysteine 133 in catalysis by the human type 2 iodothyronine deiodinase. Endocrinology. 2000; 141(12):4606-12. DOI: 10.1210/endo.141.12.7831. View

Curcio C, Baqui M, Salvatore D, Rihn B, Mohr S, Harney J . The human type 2 iodothyronine deiodinase is a selenoprotein highly expressed in a mesothelioma cell line. J Biol Chem. 2001; 276(32):30183-7. DOI: 10.1074/jbc.C100325200. View

Bianco A, Salvatore D, Gereben B, Berry M, Larsen P . Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev. 2002; 23(1):38-89. DOI: 10.1210/edrv.23.1.0455. View

Baqui M, Botero D, Gereben B, Curcio C, Harney J, Salvatore D . Human type 3 iodothyronine selenodeiodinase is located in the plasma membrane and undergoes rapid internalization to endosomes. J Biol Chem. 2002; 278(2):1206-11. DOI: 10.1074/jbc.M210266200. View

Curcio-Morelli C, Gereben B, Zavacki A, Kim B, Huang S, Harney J . In vivo dimerization of types 1, 2, and 3 iodothyronine selenodeiodinases. Endocrinology. 2003; 144(3):937-46. DOI: 10.1210/en.2002-220960. View

Peeters R, Wouters P, Kaptein E, van Toor H, Visser T, Van den Berghe G . Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J Clin Endocrinol Metab. 2003; 88(7):3202-11. DOI: 10.1210/jc.2002-022013. View

Callebaut I, Curcio-Morelli C, Mornon J, Gereben B, Buettner C, Huang S . The iodothyronine selenodeiodinases are thioredoxin-fold family proteins containing a glycoside hydrolase clan GH-A-like structure. J Biol Chem. 2003; 278(38):36887-96. DOI: 10.1074/jbc.M305725200. View

10.

Larsen P . Direct immunoassay of triiodothyronine in human serum. J Clin Invest. 1972; 51(8):1939-49. PMC: 292350. DOI: 10.1172/JCI107000. View

11.

Abuid J, Larsen P . Triiodothyronine and thyroxine in hyperthyroidism. Comparison of the acute changes during therapy with antithyroid agents. J Clin Invest. 1974; 54(1):201-8. PMC: 301541. DOI: 10.1172/JCI107744. View

12.

Saberi M, Sterling F, UTIGER R . Reduction in extrathyroidal triiodothyronine production by propylthiouracil in man. J Clin Invest. 1975; 55(2):218-23. PMC: 301739. DOI: 10.1172/JCI107924. View

13.

Geffner D, Azukizawa M, Hershman J . Propylthiouracil blocks extrathyroidal conversion of thyroxine to triiodothyronine and augments thyrotropin secretion in man. J Clin Invest. 1975; 55(2):224-9. PMC: 301740. DOI: 10.1172/JCI107925. View

14.

Inada M, Kasagi K, Kurata S, Kazama Y, Takayama H, Torizuka K . Estimation of thyroxine and triiodothyronine distribution and of the conversion rate of thyroxine to triiodothyronine in man. J Clin Invest. 1975; 55(6):1337-48. PMC: 301889. DOI: 10.1172/JCI108053. View

15.

Visser T, Docter R, Hennemann G . Subcellular localization of a rat liver enzyme converting thyroxine into tri-iodothyronine and possible involvement of essential thiol groups. Biochem J. 1976; 157(2):479-82. PMC: 1163875. DOI: 10.1042/bj1570479. View

16.

Silva J, Larsen P . Pituitary nuclear 3,5,3'-triiodothyronine and thyrotropin secretion: an explanation for the effect of thyroxine. Science. 1977; 198(4317):617-20. DOI: 10.1126/science.199941. View

17.

Silva J, Larsen P . Contributions of plasma triiodothyronine and local thyroxine monodeiodination to triiodothyronine to nuclear triiodothyronine receptor saturation in pituitary, liver, and kidney of hypothyroid rats. Further evidence relating saturation of pituitary.... J Clin Invest. 1978; 61(5):1247-59. PMC: 372646. DOI: 10.1172/JCI109041. View

18.

Lum S, Nicoloff J, Spencer C, Kaptein E . Peripheral tissue mechanism for maintenance of serum triiodothyronine values in a thyroxine-deficient state in man. J Clin Invest. 1984; 73(2):570-5. PMC: 425050. DOI: 10.1172/JCI111245. View

19.

OPPENHEIMER J, Schwartz H . Stereospecific transport of triiodothyronine from plasma to cytosol and from cytosol to nucleus in rat liver, kidney, brain, and heart. J Clin Invest. 1985; 75(1):147-54. PMC: 423420. DOI: 10.1172/JCI111667. View

20.

Visser T, Kaptein E, Terpstra O, Krenning E . Deiodination of thyroid hormone by human liver. J Clin Endocrinol Metab. 1988; 67(1):17-24. DOI: 10.1210/jcem-67-1-17. View